CoChat

Effect of weight loss on markers of triglyceride‐rich lipoprotein metabolism in the metabolic syndrome

Chan, D. C., Watts, G. F., Ng, T. W. K., Yamashita, S., Barrett, P. H. R. · 2008 · European Journal of Clinical Investigation
Cited by 60

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Abstract

Backgroud Hypertriglyceridaemia, a consistent feature of dyslipidaemia in the metabolic syndrome (MetS), is related to the extent of abdominal fat mass and altered adipocytokine secretion. We determined the effect of weight loss by dietary restriction on markers of triglyceride‐rich lipoprotein (TRL) metabolism and plasma adipocytokines. Design Thirty‐five men with MetS participated in a 16 week randomized controlled dietary intervention study. Apolipoprotein (apo) C‐III, apoB‐48, remnant‐like particle (RLP)‐cholesterol, total adiponectin, high‐molecular weight (HMW) adiponectin, and retinol‐binding protein‐4 (RBP‐4) concentrations were measured using immunoassays. Results Compared with weight maintenance (n = 15), weight loss (n = 20) significantly decreased body weight, plasma insulin, triglycerides, total cholesterol, low‐density lipoprotein (LDL)‐cholesterol and lathosterol (P < 0·05). Weight loss also decreased plasma concentrations of apoC‐III (–33%), apoB‐48 (–37%), very low‐density lipoprotein (VLDL)‐apoB (–43%), RLP‐cholesterol (–48%), and RBP‐4 (–20%), and significantly increased plasma total (+20%) and HMW‐adiponectin (+19%) concentrations. In the weight loss group, reduction in plasma apoC‐III was associated (P < 0·05) with reduction in plasma apoB‐48, VLDL‐apoB, RLP‐cholesterol and triglycerides. Increase in total adiponectin was associated (P < 0·05) with the reduction in plasma VLDL‐apoB and triglycerides. The changes in HMW‐adiponectin and RBP‐4 were not associated with changes in plasma apoB‐48, apoC‐III, VLDL‐apoB, RLP‐cholesterol or triglycerides. In multiple regression analysis including changes in visceral fat, insulin and total adiponectin concentrations, the fall in plasma apoC‐III concentration was an independent predictor of the reductions in plasma apoB‐48, VLDL‐apoB, RLP‐cholesterol and triglycerides concentrations. Conclusions In men with MetS, weight loss decreases the plasma concentrations of apoB‐48, VLDL‐apoB, RLP‐cholesterol and triglycerides. This effect could partly relate to concomitant changes in plasma apoC‐III and adiponectin concentrations that accelerate the catabolism of TRLs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2362.2008.02019.x

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Cited by

See all 60

Metadata

Authors
Chan, D. C., Watts, G. F., Ng, T. W. K., Yamashita, S., & Barrett, P. H. R.
Venue
European Journal of Clinical Investigation
Publisher
Wiley
Published
2008-09-20
Volume
38
Issue
10
Pages
743-751
ISSN
  • 0014-2972 (ISSN-L)
  • 1365-2362
OpenAlex
W2045383161
Cited by
60
References
13
FWCI
3.08
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effect of weight loss on markers of triglyceride‐rich lipoprotein metabolism in the metabolic syndrome. https://app.cochat.ai/papers/10.1111/j.1365-2362.2008.02019.x
The paper
Chan, D. C., Watts, G. F., Ng, T. W. K., Yamashita, S., & Barrett, P. H. R. (2008). Effect of weight loss on markers of triglyceride‐rich lipoprotein metabolism in the metabolic syndrome. European Journal of Clinical Investigation. https://doi.org/10.1111/j.1365-2362.2008.02019.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.